Deciphex

Deciphex are developing ergonomic digital pathology software workflows and AI to transform pathology by increasing productivity and lowering cost.

  • Stage Product In Market
  • Industry Software
  • Location Dublin, Ireland
  • Currency EUR
  • Founded March 2017
  • Employees 27
  • Incorporation Type LLC
  • Website deciphex.com

Company Summary

Pathology is in a crisis with increasing caseload and declining pathologists. Deciphex combines optimized digital pathology workflows with AI, to triage samples based on abnormality, thereby increasing productivity and profitability for users. Since formation, Deciphex has raised €5.3m in grant aid. Launched in November 2018, Patholytix Preclinical is a SAAS offering for the Pharma/CRO sectors. which has taken €420k in orders in 2019 trading.

Team

  • Donal O'Shea
    CEO & Co Founder

    A serial entrepreneur and former VP of Leica Biosystems, a renowned global player in the Digital Pathology sector. He has significant experience in building successful companies, gaining investment and exit strategies; with a global network of contacts.

  • Mark Gregson
    CTO & Co Founder

    Highly experienced CTO in digital pathology imaging software and system development, with expertise in Artificial Intelligence. Previously responsible for $250m of digital pathology and imaging system sales in various organisations.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free